RETROVIRUS TYPE C IN THE MOUSE BLADDER CARCINOMA CELL LINE MBT-2
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (6) , 1999-2001
- https://doi.org/10.1016/s0022-5347(05)67617-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extractsInternational Journal of Cancer, 1997
- Mycobacterium Cell Wall: An Alternative to Intravesical Bacillus Calmette Guerin (BCG) Therapy in Orthotopic Murine Bladder CancerJournal of Urology, 1996
- Immunotherapy of Murine Bladder Cancer with Keyhole Limpet Hemocyanin (KLH)Journal of Urology, 1993
- Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?Urological Research, 1992
- Interferon- α can alter the Lytic Susceptibility of Murine Bladder Transitional Cell Carcinoma (MBT-2) by their Original Poor Specific Cytotoxic Tumor Infiltrating LymphocytesJournal of Urology, 1992
- Superiority of Intravesical Immunotherapy with Corynebacterium Parvum and Allium Sativum in Control of Murine Bladder CancerJournal of Urology, 1987
- Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor ActivityJournal of Urology, 1987
- Surface Antigens on Transplantable Tumor Cell Lines Producing Mouse Type C VirusesJNCI Journal of the National Cancer Institute, 1977
- Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.The Journal of Experimental Medicine, 1976
- Mammalian Cells in Culture Frequently Release Type C VirusesScience, 1973